Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton … HW El-Shafey, RM Gomaa, SM El-Messery, FE Goda Bioorganic Chemistry 101, 103987, 2020 | 21 | 2020 |
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study MM Al-Sanea, A Hamdi, AAB Mohamed, HW El-Shafey, M Moustafa, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2166036, 2023 | 20 | 2023 |
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies A Hamdi, HW El-Shafey, DIA Othman, AS El-Azab, NA AlSaif, AM Alaa Bioorganic Chemistry 122, 105710, 2022 | 18 | 2022 |
Quinazoline based HSP90 inhibitors: synthesis, modeling study and ADME calculations towards breast cancer targeting HW El-Shafey, RM Gomaa, SM El-Messery, FE Goda Bioorganic & Medicinal Chemistry Letters 30 (15), 127281, 2020 | 16 | 2020 |
Development of new thiazolidine-2, 4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in … A Hamdi, M Yaseen, WA Ewes, MA Bhat, NI Ziedan, HW El-Shafey, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2231170, 2023 | 10 | 2023 |
Identification of Benzothiazoles Bearing 1, 3, 4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study WA Ewes, SS Tawfik, AM Almatary, M Ahmad Bhat, HW El-Shafey, ... Molecules 29 (13), 3186, 2024 | | 2024 |
S-Alkylated quinazolin-4 (3 H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study SS Tawfik, A Hamdi, AR Ali, AA Elgazar, HW El-Shafey, AS El-Azab, ... RSC advances 14 (36), 26325-26339, 2024 | | 2024 |